Reproducibility of LipiView Ocular Surface Interferometer (LipiView) for Measuring Tear Lipid Layer Thickness
Launched by SINGAPORE NATIONAL EYE CENTRE · Aug 30, 2013
Trial Information
Current as of May 09, 2025
Completed
Keywords
ClinConnect Summary
This study will be conducted in compliance with the protocol, SGCP and the applicable regulatory requirements.
Dry eye is a condition that affects 5-35% of the population.11 Common symptoms of this condition include eye irritation, heaviness of the eyelids, visual disturbances, tearing and light sensitivity.12 This significantly impacts the quality of life and vision of dry eye patients. In addition, there is a significant socioeconomic burden. In 2009, 54,051 patients sought treatment for dry eye in the Singapore National Eye Centre (SNEC). In total, the costs for dry eye medication amoun...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Volunteers that are medically fit and willing to participate in this study.
- Exclusion Criteria:
- • No eye surgery done within the previous 3 months
- • Active ocular surface conditions such as infection or pterygium that may affect tear film stability.
- • Any other specified reason as determined by clinical investigator.
About Singapore National Eye Centre
The Singapore National Eye Centre (SNEC) is a premier institution dedicated to advancing ophthalmic care through innovative research and clinical excellence. As a leading clinical trial sponsor, SNEC focuses on improving the diagnosis and treatment of a wide range of eye conditions, leveraging cutting-edge technologies and methodologies. Committed to enhancing patient outcomes, SNEC collaborates with a network of healthcare professionals and researchers to conduct rigorous clinical trials that contribute to the global understanding of ocular health. Their comprehensive approach integrates patient care with scientific inquiry, ensuring that advancements in eye care are both evidence-based and aligned with the needs of the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Singapore, , Singapore
Patients applied
Trial Officials
Louis Tong, PhD
Principal Investigator
Singapore National Eye Centre
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials